BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Generex Biotechnology Corporation 

33 Harbour Square
Suite 202
Toronto  Ontario  M5J 2G2  Canada
Phone: 416-364-2551 Fax: 416-364-9363


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Delivery





 Company News
Generex Biotechnology Corporation (GNBT) Announces $2,075,000 Capital Investment 3/27/2014 9:30:29 AM    More...
Generex Biotechnology Corporation (GNBT)/Antigen Express, Inc. (GNBT) Announces Participation On Panel At Upcoming Cancer Immunotherapeutics Symposium 3/26/2014 7:44:03 AM    More...
Generex Biotechnology Corporation (GNBT) Subsidiary Antigen Express Receives Patents For Vaccines Targeting HPV Induced Cancers And Influenza 3/5/2014 10:42:12 AM    More...
Generex Biotechnology Corporation (GNBT) Announces Publication Of Biomarker Studies Related To The Antigen Express Novel Immunotherapeutic AE37 In Prostate Cancer Patients 2/27/2014 10:22:06 AM    More...
Generex Biotechnology Corporation (GNBT)/Antigen Express, Inc. (GNBT) Interview On Clear Channel Business Talk Radio DFW 1190AM By Host Michael Yorba 2/13/2014 9:41:01 AM    More...
Generex Biotechnology Corporation (GNBT) Provides Update On Antigen Express Phase II AE37 Breast Cancer Vaccine Trial 2/12/2014 10:04:39 AM    More...
Generex Biotechnology Corporation (GNBT) Announces Completion Of Enrollment Of Antigen Express Phase II AE37 Breast Cancer Vaccine Trial 1/13/2014 12:10:11 PM    More...
Generex Biotechnology Corporation (GNBT) Announces Selection Of Antigen Express Technology For Keynote Presentation At 2014 TIDES Conference 1/9/2014 7:48:30 AM    More...
Generex Biotechnology Corporation (GNBT)/Antigen Express, Inc. (GNBT) Announce Database Lock Of AE37 Breast Cancer Vaccine Trial 1/7/2014 10:27:59 AM    More...
Generex Biotechnology Corporation (GNBT) Provides Update on Generex Oral-lyn™ Conference Call 9/27/2013 8:49:19 AM    More...
12345678910...

//-->